1093376-83-0Relevant articles and documents
Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells
Delaine, Tamara,Cumpstey, Ian,Ingrassia, Laurent,Le Mercier, Marie,Okechukwu, Paul,Leffler, Hakon,Kiss, Robert,Nilsson, Ulf J.
supporting information; experimental part, p. 8109 - 8114 (2009/12/07)
Aromatic 3,3?-diesters of thiodigalactoside were synthesized in a rapid three-step sequence from commercially available thiodigalactoside and evaluated as inhibitors of cancer- and immunity-related galectins. For each of galectins-1, -3, -7, and -9N-terminal domain, aromatic 3,3′-diesters of thiodigalactoside were found to have affinities in the low micromolar range, which represents a 7-70 fold enhancement over thiodigalactoside itself. No significant improvement was found for galectin-8 N-terminal domain. Two of the compounds were selected for testing in cell culture and were shown to have potent antimigratory effects on human PC-3 prostate and human A549 nonsmall-cell lung cancer cells.